Stock listing

NASDAQ:RNAM Avidity Biosciences, Inc Stock

Follow Avidity Biosciences, Inc into a list and get an email when it puts out news.

Last close · NASDAQ:RNAM

$71.34 USD

Close on Feb 26, 2026 · No longer trades

Jun 12, 2020 to last close +150.3% · weekly closes, Jun 12, 2020 – Feb 26, 2026
Lowest – highest close
$4.87 – $72.93 USDSince Jun 12, 2020 · lowest Oct 27, 2023 · highest Feb 3, 2026

Delisted NASDAQ:RNAM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RNAM
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Avidity Biosciences, Inc on 6ix

Decks
13 decks · latest Oct 27, 2025

Decks

DeckKindSlidesDate
Merger or Acquisition (October 2025)Merger or acquisition28 slidesOct 27, 2025
Investor Day (September 2025)Investor day24 slidesSep 10, 2025
Investor Day (June 2025)Investor day38 slidesJun 9, 2025
Investor Day (March 2025)Investor day32 slidesMar 17, 2025
Investor Day (November 2024)Investor day38 slidesNov 12, 2024
Technical Presentation (August 2024)Technical25 slidesAug 9, 2024
Technical Presentation (June 2024)Technical47 slidesJun 12, 2024
Investor Day (March 2024)Investor day35 slidesMar 4, 2024
Investor Day (April 2023)Investor day45 slidesApr 27, 2023
Technical Presentation (December 2022)Technical65 slidesDec 14, 2022
All 13 decks
DeckKindSlidesDate
Technical Presentation (December 2021)Technical66 slidesDec 9, 2021
Investor Day (August 2021)Investor day60 slidesAug 2, 2021
Investor Day (May 2021)Investor day47 slidesMay 19, 2021

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Edward M. Kaye
Other companies: Stoke Therapeutics, Inc. (Director · Since at least Jun 18, 2019); Cytokinetics, Incorporated (Director · Since at least May 18, 2016); Sarepta Therapeutics, Inc. (Chair of Scientific Advisory Board · Apr 24, 2012 – Nov 4, 2026 · Past)
Director · Since at least Jun 11, 2020
Michael MacLean
Other companies: Research Alliance Corporation III (Director · Since at least May 19, 2026); CAMP4 Therapeutics Corporation (Director · Since at least Mar 24, 2026); Verve Therapeutics Inc (Director · Since at least Jun 5, 2025)
Chief Financial Officer · Since at least Aug 6, 2025
Steven George Hughes
Other companies: Atrium Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 26, 2026); Arcturus Therapeutics Holdings Inc. (Chief Development Officer · Feb 18, 2020 – Dec 18, 2020 · Past); VivoSim Labs, Inc. (Chief Medical Officer · Aug 1, 2018 – Aug 16, 2019 · Past)
Chief Medical Officer · Since at least Jan 6, 2025
Simona Skerjanec
Other companies: Atrium Therapeutics, Inc. (Director · Since at least Nov 10, 2025); Immunic, Inc. (Director · Since at least Jul 22, 2024)
Director · Since at least May 14, 2024
Arthur Levin
Other companies: Stoke Therapeutics, Inc. (Director · Since at least Jun 18, 2019)
Director · Since at least Jun 11, 2020
W. Michael Flanagan
Other companies: Atrium Therapeutics, Inc. (Director · Since at least Nov 10, 2025)
Chief Scientific Officer · Since at least Jan 21, 2021
Eric MosbrookerChief Commercial Officer · Since at least Aug 25, 2021
Teresa McCarthyChief Human Resources Officer · Since at least May 11, 2021

Open People

Log in to ask 6ix AI your own questions about Avidity Biosciences, Inc.